2020
DOI: 10.1007/s00284-020-01903-w
|View full text |Cite
|
Sign up to set email alerts
|

Cholesterol-Lowering Effects of Lactobacillus Species

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
39
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(39 citation statements)
references
References 44 publications
0
39
0
Order By: Relevance
“…Some genera found in the fermented foods in this study, especially Lactococcus, Lactobacillus and Leuconostoc, have been known to have probiotic potential [46,47] and had positive effects on health. For example, Some Lactobacillus species have been reported to have cholesterol lowering properties [48] and reduce risks of microbial infection such as in the case of Helicobacter pylori [49,50]. Lactococcus species have been described for therapeutic treatments for various diseases, e.g.…”
Section: Plos Onementioning
confidence: 99%
“…Some genera found in the fermented foods in this study, especially Lactococcus, Lactobacillus and Leuconostoc, have been known to have probiotic potential [46,47] and had positive effects on health. For example, Some Lactobacillus species have been reported to have cholesterol lowering properties [48] and reduce risks of microbial infection such as in the case of Helicobacter pylori [49,50]. Lactococcus species have been described for therapeutic treatments for various diseases, e.g.…”
Section: Plos Onementioning
confidence: 99%
“…In modern societies, high-fat and high-sucrose diets usually lead to hypercholesterolemia and atherosclerosis due to increased cholesterol levels [ 22 ]. Cholesterol is the principal lipid in the bile [ 23 ]. A high serum cholesterol level is a risk factor for cardiovascular diseases [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…Lactobacillus species are also known to generate short-chain fatty acids (SCFAs) such as acetate, butyrate [163] and propionate [164] in the gut as health-associated metabolic by-products. Other recent reviews have focused on the immunomodulatory capacities [165] and activities in cholesterol homeostasis [166] depending on their presence and abundance in the gut. These SCFAs in addition to the biogenic compounds listed represent a group of natively produced compounds with potential use in a variety of therapies.…”
Section: Delivery Of Native and Recombinant Productsmentioning
confidence: 99%